Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAEMONETICS CORP Director's Dealing 2010

May 4, 2010

31565_dirs_2010-05-04_f11bd2a3-512b-434d-8f6d-6f1c33d5e177.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-04-30

Reporting Person: LOPEZ ALICIA R (VP, Corporate Affairs)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-04-30 Common Stock P 318 $45.7045 Acquired 11009 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $26.105 2014-05-05 Common Stock (10000) 10000 Direct
Non-Qualified Stock Option (right to buy) $31.66 2012-04-29 Common Stock (20000) 20000 Direct
Non-Qualified Stock Option (right to buy) $33.15 2011-04-30 Common Stock (17000) 17000 Direct
Non-Qualified Stock Option (right to buy) $41.15 2012-07-27 Common Stock (17000) 17000 Direct
Non-Qualified Stock Option (right to buy) $51.07 2014-10-24 Common Stock (14159) 14159 Direct
Non-Qualified Stock Option (right to buy) $52.76 2013-05-05 Common Stock (14891) 14891 Direct
Non-Qualified Stock Option (right to buy) $52.94 2016-10-27 Common Stock (7732) 7732 Direct
Non-Qualified Stock Option (right to buy) $54.55 2015-10-22 Common Stock (14294) 14294 Direct

Footnotes

F1: Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction.

F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.

F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

F4: Grant to reporting person of right to buy shares of common stock exercisable 100% on 4/1/2011. Grant was made under 2005 Long Term Incentive Compensation Plan.